{"componentChunkName":"component---src-templates-chapter-level-1-chapter-level-1-tsx","path":"/topics/post-traumatic-stress-disorder/prescribing-information/","result":{"pageContext":{"chapter":{"id":"2022c3bf-f856-5c11-b2fa-f455afe14e13","slug":"prescribing-information","fullItemName":"Prescribing information","depth":1,"htmlHeader":"<!-- begin field 1e037182-2015-42e8-b17e-a31bf06f89b5 --><h1>Prescribing information</h1><!-- end field 1e037182-2015-42e8-b17e-a31bf06f89b5 -->","summary":null,"htmlStringContent":"<!-- begin item 134fa103-62e2-4658-83d7-dcbd30416c48 --><!-- begin field c4766801-8034-401d-96ac-a9e800c08d3c --><p>Important aspects of prescribing information relevant to primary healthcare are covered in this section specifically for the drugs recommended in this CKS topic. For further information on contraindications, cautions, drug interactions, and adverse effects, see the <a data-hyperlink-id=\"f57fed51-e31b-49b3-b412-a98d0051dc6f\" href=\"http://www.medicines.org.uk/emc/\">electronic Medicines Compendium</a> (eMC), or the <a data-hyperlink-id=\"1c1c6eb8-879f-4e5e-b302-a98d0051dcec\" href=\"https://bnf.nice.org.uk/\">British National Formulary</a> (BNF).</p><!-- end field c4766801-8034-401d-96ac-a9e800c08d3c --><!-- end item 134fa103-62e2-4658-83d7-dcbd30416c48 -->","topic":{"id":"533afaeb-861a-55f6-ae85-a0876ad3c4ab","topicId":"4676b2a0-1d7e-49c9-a79f-d2d558307370","topicName":"Post-traumatic stress disorder","slug":"post-traumatic-stress-disorder","lastRevised":"Last revised in October 2020","chapters":[{"id":"6114e299-9845-5fc0-92b9-5c972e9c90f1","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"52893b93-e424-59ff-84a1-7dd9d9c8621a","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"4be53e3f-4d5e-556c-a6ed-aeebfd10913f","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"5d1733e3-23d7-5fe8-b3cd-8444b4097187","slug":"changes","fullItemName":"Changes"},{"id":"3b6b3dc7-0b46-5df1-a1c8-9e7d1cfc1bf5","slug":"update","fullItemName":"Update"}]},{"id":"924b02ab-fe04-5ca6-bfe4-efb3fa6b1e5c","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"ddf247aa-bfb1-5234-9e83-9df355d28fbb","slug":"goals","fullItemName":"Goals"},{"id":"afdc351f-4815-5456-9d22-1e17d70923b9","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"fa4ae569-9575-57de-8a77-f97e6acf134e","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"441dbc06-ae69-5d87-b878-08acf874b06d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"380572c6-6c66-5ecd-bb4a-907f070efec7","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"6e104865-1bd8-5bbc-a881-5acad7b59200","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"f7a4b151-95d9-5da2-8bbb-3515fae24bcc","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"e8e51f81-8392-5390-8f30-d6a8e5f38014","slug":"definition","fullItemName":"Definition"},{"id":"0826975d-685e-520a-9295-f3528d50f411","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"f35f4ff7-1d48-5dc1-acb1-c6b04aee33a8","slug":"prevalence","fullItemName":"Prevalence"},{"id":"3c03bd4a-5a08-5bb7-8f67-78a04deaff9a","slug":"prognosis","fullItemName":"Prognosis"},{"id":"406fb31f-fa1e-5214-b69e-e347e6875458","slug":"complications","fullItemName":"Complications"}]},{"id":"331796fb-0b83-5add-8e42-d0b72a892df8","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"2ee24530-3791-5949-93f2-a856c919f68d","slug":"diagnosis","fullItemName":"Diagnosis"}]},{"id":"fae5c916-6c3e-5d0f-8700-e051eb95a992","fullItemName":"Management","slug":"management","subChapters":[{"id":"3a0b4bd2-81cd-5c2c-bb02-7c2734e8ebed","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"2022c3bf-f856-5c11-b2fa-f455afe14e13","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"8c49cc16-aec3-5fe6-98f3-6facc85e65a4","slug":"ssris","fullItemName":"SSRIs"},{"id":"21362ceb-fea6-5f5e-a2fe-3a66b96f23bb","slug":"venlafaxine","fullItemName":"Venlafaxine"}]},{"id":"ace3b310-05bb-5555-9074-19f51f5bcc46","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"94089c18-8f8a-5c71-b9fa-98bab016d27c","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"fb1c0b33-ff77-5312-9d64-544591ee5a16","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"ab823271-5683-5fa8-9990-359b8361a067","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"4977229b-c104-593f-9254-5b46fd4cef6b","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"aa78f3e8-f7e9-5ec9-98a7-ab3a2ded7822","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"40d90bf9-fb45-51a8-8085-ff7f6501f6e7","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"ad5c3e2a-1074-579a-82d5-e2675befc03f","fullItemName":"References","slug":"references","subChapters":[]}]},"subChapters":[{"id":"8c49cc16-aec3-5fe6-98f3-6facc85e65a4","slug":"ssris","fullItemName":"SSRIs","summary":""},{"id":"21362ceb-fea6-5f5e-a2fe-3a66b96f23bb","slug":"venlafaxine","fullItemName":"Venlafaxine","summary":""}]}}},"staticQueryHashes":["3666801979"]}